ورود
مقالات فارسیISIکنفرانسهاژورنالها

Association of serum prolactin levels and thyroid hormones with poisoned patient outcome

محل انتشار: مجله سم شناسی پزشکی آسیا اقیانوسیه، دوره: 10، شماره: 3
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 145

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1280642

شناسه ملی سند علمی:

JR_PJMT-10-3_005

تاریخ نمایه سازی: 11 مهر 1400

چکیده مقاله:

Background: In acute and chronic phases of severe diseases, endocrine changes occur. Some hormones, such as prolactin (PRL) and thyroid hormones, were considered predictors of ICU patients' outcomes. The present study evaluates thyroid hormone profile, serum PRL level, and their relationship with ICU poisoned patients' mortality rate.Methods: This study included ۱۴۰ inpatients in the Toxicology Intensive Care Unit (TICU) who enrolled in a prospective study of a single center and observational. After admission to the ICU, the researchers collected venous blood samples from all patients directly. Concurrently, the APACHE II score was calculated. The collected samples analysis was performed based on the entire triiodothyronine (T۳), thyroxine (T۴), thyroid-stimulating hormone (TSH), and PRL level.Results: One hundred and forty subjects were studied, of which ۱۰۹ (۷۵.۸۵%) were male with a mean age of ۳۴.۱۷ ± ۱۴.۰۱. One hundred and eighteen patients were survivors with a mean age of ۳۳.۲۹ ±۱۳.۷۶. In contrast, ۲۲ patients with a mean age of ۳۸.۹۱ ±۱۴.۶۹ died. The model of PRL combined with APACHE II score (OR ۱.۱۷, ۹۵% CI ۱.۰۶ to ۱.۲۸, P-value =۰.۰۰۱) was the best model for predicting post-ICU mortality in our study.Conclusions: This study’s results are consistent with the previous research, indicating a higher incidence of thyroid and PRL hormone changes in patients hospitalized in the ICU.   It can be concluded that the presence of PRL based on the APACHE II score can lead us to be more precise in predicting the outcome of poisoning in hospitalized patients.

کلیدواژه ها:

APACHE II score ، Mortality ، Prolactin ، Thyroid hormones

نویسندگان

Arezou Mahdavinejad

Toxicology Research Center, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Peyman Erfan Talab evini

Toxicology Research Center, Excellence Center of Clinical Toxicology AND Department of Clinical Toxicology, Loghman Hakim Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mitra Rahimi

Shahid Beheshti University of Medical Sciences

Shahin Shadnia

Toxicology Research Center, Excellence Center of Clinical Toxicology AND Department of Clinical Toxicology, Loghman Hakim Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Reference:Abubaker Z, Nisar M, Jamshed A, Abbas M, Hashmi K, ...
  • Yang S, Wang Z, Liu Z, Wang J, Ma L. ...
  • Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, ...
  • Lee H, Lim CW, Hong HP, Ju JW, Jeon YT, ...
  • Van den Berghe G, Wouters P, Weekers F, Mohan S, ...
  • Van den Berghe G. Endocrine evaluation of patients with critical ...
  • Ilias I, Stamoulis K, Armaganidis A, Lyberopoulos P, Tzanela M, ...
  • Akbaş T, Deyneli O, Sönmez FT, Akalın S. The pituitary–gonadal–thyroid ...
  • Harris J, Stanford PM, Oakes SR, Ormandy CJ. Prolactin and ...
  • Legorreta-Haquet M V, Chávez-Rueda K, Montoya-Díaz E, Arriaga-Pizano L, Silva-García ...
  • López-Rincón G, Mancilla R, Pereira-Suárez AL, Martínez-Neri PA, Ochoa-Zarzosa A, ...
  • Mullur R, Liu Y-Y, Brent GA. Thyroid hormone regulation of ...
  • Ortiga‐Carvalho TM, Chiamolera MI, Pazos‐Moura CC, Wondisford FE. Hypothalamus‐pituitary‐thyroid axis. ...
  • Rashidi MA, MAHABADI HA, Khavanin A. Evaluation of the effects ...
  • Economidou F, Douka E, Tzanela M, Nanas S, Kotanidou A. ...
  • Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab ...
  • Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function ...
  • Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. ...
  • Van den Berghe G. Non-thyroidal illness in the ICU: a ...
  • Kumar KVSH, Kapoor U, Kalia R, Chandra NSA, Singh P, ...
  • Kanji S, Neilipovitz J, Neilipovitz B, Kim J, Haddara WMR, ...
  • Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser ...
  • Meyer S, Schuetz P, Wieland M, Nusbaumer C, Mueller B, ...
  • El-Ella SSA, El-Mekkawy MS, El-Dihemey MA. Prevalence and prognostic value ...
  • Mazzeo AT, Guaraldi F, Filippini C, Tesio R, Settanni F, ...
  • Nguyen DN, Huyghens L, Schiettecatte J, Smitz J, Vincent J-L. ...
  • Téblick A, Langouche L, Van den Berghe G. Anterior pituitary ...
  • Van den Berghe G. Novel insights into the neuroendocrinology of ...
  • Savino W. Prolactin: an immunomodulator in health and disease. Endocr ...
  • Olivecrona Z, Dahlqvist P, Koskinen L-OD. Acute neuro-endocrine profile and ...
  • Frost SA, Alexandrou E, Bogdanovski T, Salamonson Y, Davidson PM, ...
  • Yalçın M, Gödekmerdan E, Tayfur K, Yazman S, Ürkmez M, ...
  • Lee JH, Hwang SY, Kim HR, Kim YW, Kang MJ, ...
    • نمایش کامل مراجع